Verve Therapeutics Statistics
Total Valuation
VERV has a market cap or net worth of $421.34 million. The enterprise value is -$25.41 million.
Important Dates
The next estimated earnings date is Wednesday, May 7, 2025, before market open.
| Earnings Date | May 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
VERV has 88.80 million shares outstanding. The number of shares has increased by 32.02% in one year.
| Current Share Class | 88.80M |
| Shares Outstanding | 88.80M |
| Shares Change (YoY) | +32.02% |
| Shares Change (QoQ) | +2.65% |
| Owned by Insiders (%) | 5.08% |
| Owned by Institutions (%) | 67.79% |
| Float | 65.03M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 13.68 |
| Forward PS | 18.57 |
| PB Ratio | 0.94 |
| P/TBV Ratio | 0.87 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.65, with a Debt / Equity ratio of 0.14.
| Current Ratio | 12.65 |
| Quick Ratio | 12.29 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -36.36% and return on invested capital (ROIC) is -23.09%.
| Return on Equity (ROE) | -36.36% |
| Return on Assets (ROA) | -20.41% |
| Return on Invested Capital (ROIC) | -23.09% |
| Return on Capital Employed (ROCE) | -37.83% |
| Revenue Per Employee | $118,000 |
| Profits Per Employee | -$725,215 |
| Employee Count | 274 |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, VERV has paid $349,000 in taxes.
| Income Tax | 349,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -63.78% in the last 52 weeks. The beta is 1.78, so VERV's price volatility has been higher than the market average.
| Beta (5Y) | 1.78 |
| 52-Week Price Change | -63.78% |
| 50-Day Moving Average | 6.86 |
| 200-Day Moving Average | 5.99 |
| Relative Strength Index (RSI) | 31.59 |
| Average Volume (20 Days) | 1,134,434 |
Short Selling Information
The latest short interest is 15.27 million, so 17.20% of the outstanding shares have been sold short.
| Short Interest | 15.27M |
| Short Previous Month | 14.86M |
| Short % of Shares Out | 17.20% |
| Short % of Float | 23.49% |
| Short Ratio (days to cover) | 10.83 |
Income Statement
In the last 12 months, VERV had revenue of $32.33 million and -$198.71 million in losses. Loss per share was -$2.35.
| Revenue | 32.33M |
| Gross Profit | 9.48M |
| Operating Income | -228.66M |
| Pretax Income | -192.38M |
| Net Income | -198.71M |
| EBITDA | -221.91M |
| EBIT | -228.66M |
| Loss Per Share | -$2.35 |
Full Income StatementBalance Sheet
The company has $524.28 million in cash and $69.98 million in debt, giving a net cash position of $454.30 million or $5.12 per share.
| Cash & Cash Equivalents | 524.28M |
| Total Debt | 69.98M |
| Net Cash | 454.30M |
| Net Cash Per Share | $5.12 |
| Equity (Book Value) | 493.40M |
| Book Value Per Share | 5.56 |
| Working Capital | 499.84M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$157.69 million and capital expenditures -$3.74 million, giving a free cash flow of -$161.43 million.
| Operating Cash Flow | -157.69M |
| Capital Expenditures | -3.74M |
| Free Cash Flow | -161.43M |
| FCF Per Share | -$1.82 |
Full Cash Flow StatementMargins
| Gross Margin | 29.33% |
| Operating Margin | -707.23% |
| Pretax Margin | -613.51% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
VERV does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -32.02% |
| Shareholder Yield | -32.02% |
| Earnings Yield | -46.33% |
| FCF Yield | -37.64% |
Analyst Forecast
The average price target for VERV is $25.50, which is 437.41% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $25.50 |
| Price Target Difference | 437.41% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | -11.41% |
| EPS Growth Forecast (5Y) | 8.05% |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
VERV has an Altman Z-Score of 0.7 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.7 |
| Piotroski F-Score | 3 |